1. Home
  2. MNKD vs HLIO Comparison

MNKD vs HLIO Comparison

Compare MNKD & HLIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNKD
  • HLIO
  • Stock Information
  • Founded
  • MNKD 1991
  • HLIO 1970
  • Country
  • MNKD United States
  • HLIO United States
  • Employees
  • MNKD N/A
  • HLIO N/A
  • Industry
  • MNKD Biotechnology: Pharmaceutical Preparations
  • HLIO Metal Fabrications
  • Sector
  • MNKD Health Care
  • HLIO Industrials
  • Exchange
  • MNKD Nasdaq
  • HLIO Nasdaq
  • Market Cap
  • MNKD 1.6B
  • HLIO 1.4B
  • IPO Year
  • MNKD 2004
  • HLIO N/A
  • Fundamental
  • Price
  • MNKD $5.03
  • HLIO $32.01
  • Analyst Decision
  • MNKD Buy
  • HLIO Buy
  • Analyst Count
  • MNKD 6
  • HLIO 2
  • Target Price
  • MNKD $8.92
  • HLIO $58.00
  • AVG Volume (30 Days)
  • MNKD 1.9M
  • HLIO 204.2K
  • Earning Date
  • MNKD 05-07-2025
  • HLIO 05-07-2025
  • Dividend Yield
  • MNKD N/A
  • HLIO 1.13%
  • EPS Growth
  • MNKD N/A
  • HLIO 2.65
  • EPS
  • MNKD 0.10
  • HLIO 1.17
  • Revenue
  • MNKD $285,504,000.00
  • HLIO $805,900,000.00
  • Revenue This Year
  • MNKD $14.66
  • HLIO $1.26
  • Revenue Next Year
  • MNKD $14.27
  • HLIO $5.89
  • P/E Ratio
  • MNKD $50.50
  • HLIO $27.36
  • Revenue Growth
  • MNKD 43.50
  • HLIO N/A
  • 52 Week Low
  • MNKD $3.97
  • HLIO $30.83
  • 52 Week High
  • MNKD $7.63
  • HLIO $57.29
  • Technical
  • Relative Strength Index (RSI)
  • MNKD 37.28
  • HLIO 25.66
  • Support Level
  • MNKD $5.16
  • HLIO $33.10
  • Resistance Level
  • MNKD $5.12
  • HLIO $35.03
  • Average True Range (ATR)
  • MNKD 0.14
  • HLIO 1.27
  • MACD
  • MNKD 0.01
  • HLIO -0.08
  • Stochastic Oscillator
  • MNKD 25.45
  • HLIO 18.35

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.

About HLIO Helios Technologies Inc.

Helios Technologies Inc is a industrial technology company that develops, manufactures, and markets solutions for the hydraulics and electronics markets. It operates under two business segments: Hydraulics and Electronics. The Hydraulics segment designs and manufactures hydraulic cartridge valves, hydraulic quick release couplings as well as engineers complete hydraulic systems. The Electronics segment designs and manufactures customized electronic controls systems and displays for a variety of end markets including industrial and mobile, recreational and health and wellness.

Share on Social Networks: